Security National Trust’s Teva Pharmaceuticals TEVA Stock Holding History

Security National Trust’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$12K	Hold	1,241	–	–	﹤0.01%	341
2021 Q2	$12K	Hold	1,241	–	–	﹤0.01%	350
2021 Q1	$14K	Hold	1,241	–	–	﹤0.01%	344
2020 Q4	$12K	Hold	1,241	–	–	﹤0.01%	347
2020 Q3	$11K	Hold	1,241	–	–	﹤0.01%	345
2020 Q2	$15K	Hold	1,241	–	–	﹤0.01%	330
2020 Q1	$11K	Hold	1,241	–	–	﹤0.01%	359
2019 Q4	$12K	Hold	1,241	–	–	﹤0.01%	358
2019 Q3	$9K	Hold	1,241	–	–	﹤0.01%	327
2019 Q2	$11K	Hold	1,241	–	–	﹤0.01%	325
2019 Q1	$19K	Hold	1,241	–	–	0.01%	294
2018 Q4	$19K	Hold	1,241	–	–	0.01%	281
2018 Q3	$27K	Hold	1,241	–	–	0.01%	286
2018 Q2	$30K	Hold	1,241	–	–	0.01%	287
2018 Q1	$21K	Hold	1,241	–	–	0.01%	300
2017 Q4	$24K	Hold	1,241	–	–	0.01%	298
2017 Q3	$22K	Sell	1,241 -4,420	-78%	-$99.5K	0.01%	309
2017 Q2	$188K	Sell	5,661 -3,780	-40%	-$117K	0.06%	172
2017 Q1	$303K	Sell	9,441 -870	-8%	-$29.7K	0.1%	144
2016 Q4	$374K	Sell	10,311 -4,360	-30%	-$174K	0.13%	125
2016 Q3	$675K	Buy	14,671 +100	+0.7%	+$5.22K	0.25%	89
2016 Q2	$732K	Buy	14,571 +1,000	+7%	+$53.2K	0.27%	86
2016 Q1	$726K	Hold	13,571	–	–	0.27%	86
2015 Q4	$890K	Sell	13,571 -150	-1%	-$9.27K	0.35%	76
2015 Q3	$775K	Hold	13,721	–	–	0.3%	81
2015 Q2	$811K	Hold	13,721	–	–	0.29%	82
2015 Q1	$855K	Hold	13,721	–	–	0.3%	79
2014 Q4	$789K	Buy	13,721 +1,241	+10%	+$69.1K	0.29%	81
2014 Q3	$671K	Hold	12,480	–	–	0.27%	86
2014 Q2	$654K	Hold	12,480	–	–	0.26%	90
2014 Q1	$659K	Sell	12,480 -50	-0.4%	-$2.31K	0.27%	87
2013 Q4	$503K	Sell	12,530 -880	-7%	-$34.7K	0.21%	103
2013 Q3	$507K	Buy	13,410 +250	+2%	+$9.75K	0.23%	101
2013 Q2	$516K	Buy	+13,160	New	+$512K	0.25%	91

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Security National Trust's TEVA Position: Q3 2021 in Review

Security National Trust held its Teva Pharmaceuticals (TEVA) position steady in Q3 2021 at 1,241 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #341.

Security National Trust first reported a position in TEVA in Q2 2013 and has held it in 34 quarters since. The position peaked at $890K in Q4 2015. 429 funds tracked by Wall St. Rank hold TEVA as of Q3 2021.

Security National Trust held 1,241 shares of Teva Pharmaceuticals worth $12K as of Q3 2021.
Security National Trust left its Teva Pharmaceuticals share count unchanged in Q3 2021.
Teva Pharmaceuticals made up ﹤0.01% of Security National Trust's portfolio in Q3 2021, its #341 holding.
Security National Trust first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 34 quarters since.
Security National Trust's Teva Pharmaceuticals position peaked at $890K in Q4 2015.
429 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2021.

Based on Security National Trust's 13F filing for Q3 2021, filed 4 Oct 2021.